Cell-based kinase assays in HTS Benjamin Bader
Cell-based kinase assays in HTS Benjamin Bader
Cell-based kinase assays in HTS Benjamin Bader
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Summary & Conclusions<br />
• K<strong>in</strong>ases rema<strong>in</strong> <strong>in</strong>terest<strong>in</strong>g target class <strong>in</strong> pharmaceutical research<br />
• Specific and efficient cell-<strong>based</strong> <strong>k<strong>in</strong>ase</strong> <strong>assays</strong> are essential <strong>in</strong> pharma<br />
research projects<br />
• Homogenous assay systems fit best to Bayers lead discovery platform<br />
• Positive experience at Bayer with EFC-technology, HTRF and<br />
Lanthascreen<br />
• EFC-technology <strong>in</strong>terest<strong>in</strong>g for Tyr-K<strong>in</strong>ase u<strong>HTS</strong><br />
• Lanthascreen technology positioned for secondary test<strong>in</strong>g<br />
• HTRF positioned for u<strong>HTS</strong> and secondary test<strong>in</strong>g<br />
28 HTRF-symposium 2013<br />
281<br />
28
![HTRF meeting_130426_villa_pour pdf [Mode de compatibilité]](https://img.yumpu.com/22345646/1/190x135/htrf-meeting-130426-villa-pour-pdf-mode-de-compatibilitac.jpg?quality=85)
Change language